Cover Image
市場調查報告書

Vanda Pharmaceuticals Inc.的產品平台分析

Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 277773
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Vanda Pharmaceuticals Inc.的產品平台分析 Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 31 Pages
簡介

Vanda Pharmaceuticals Inc.是總公司在美國的生物科技企業,進行中樞神經系統疾病治療藥的開發及商品化。該公司的開發中產品Fanapt是治療成人的思覺失調症的非典型抗精神病藥物。以外,擁有降低酒精成癮(酒精中毒)患者的飲酒慾望的藥等。

本報告提供Vanda Pharmaceuticals Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Vanda Pharmaceuticals Inc. 的基本資料

  • Vanda Pharmaceuticals Inc. 概要
  • 主要資訊
  • 企業資料

Vanda Pharmaceuticals Inc. :R&D概要

  • 主要的治療範圍

Vanda Pharmaceuticals Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Vanda Pharmaceuticals Inc. :開發中產品概況

  • 後期階段產品開發中產品
    • 登記前階段的產品/聯合治療模式
    • 申請結束/拒絕、撤回產品/聯合治療模式
  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式

Vanda Pharmaceuticals Inc. :藥物簡介

  • tasimelteon
  • iloperidone
  • tradipitant

Vanda Pharmaceuticals Inc. :開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Vanda Pharmaceuticals Inc. :最新的開發平台資訊

Vanda Pharmaceuticals Inc. :開發休止的計劃

Vanda Pharmaceuticals Inc. :開發中止的開發中產品

Vanda Pharmaceuticals Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07043CDB

Summary

Global Markets Direct's, 'Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015', provides an overview of the Vanda Pharmaceuticals Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vanda Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vanda Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vanda Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vanda Pharmaceuticals Inc.'s pipeline products

Reasons to buy

  • Evaluate Vanda Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vanda Pharmaceuticals Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vanda Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vanda Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vanda Pharmaceuticals Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vanda Pharmaceuticals Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vanda Pharmaceuticals Inc. Snapshot
    • Vanda Pharmaceuticals Inc. Overview
    • Key Information
    • Key Facts
  • Vanda Pharmaceuticals Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Vanda Pharmaceuticals Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Vanda Pharmaceuticals Inc. - Pipeline Products Glance
    • Vanda Pharmaceuticals Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Filing rejected/Withdrawn Products/Combination Treatment Modalities
    • Vanda Pharmaceuticals Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • Vanda Pharmaceuticals Inc. - Drug Profiles
    • tasimelteon
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • iloperidone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tradipitant
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Vanda Pharmaceuticals Inc. - Pipeline Analysis
    • Vanda Pharmaceuticals Inc. - Pipeline Products by Target
    • Vanda Pharmaceuticals Inc. - Pipeline Products by Route of Administration
    • Vanda Pharmaceuticals Inc. - Pipeline Products by Molecule Type
    • Vanda Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action
  • Vanda Pharmaceuticals Inc. - Recent Pipeline Updates
  • Vanda Pharmaceuticals Inc. - Dormant Projects
  • Vanda Pharmaceuticals Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • iloperidone
      • tasimelteon
  • Vanda Pharmaceuticals Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vanda Pharmaceuticals Inc., Key Information
  • Vanda Pharmaceuticals Inc., Key Facts
  • Vanda Pharmaceuticals Inc. - Pipeline by Indication, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Stage of Development, 2015
  • Vanda Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2015
  • Vanda Pharmaceuticals Inc. - Pre-Registration, 2015
  • Vanda Pharmaceuticals Inc. - Filing rejected/Withdrawn, 2015
  • Vanda Pharmaceuticals Inc. - Phase II, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Target, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Route of Administration, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Molecule Type, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2015
  • Vanda Pharmaceuticals Inc. - Recent Pipeline Updates, 2015
  • Vanda Pharmaceuticals Inc. - Dormant Developmental Projects,2015
  • Vanda Pharmaceuticals Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Stage of Development, 2015
  • Vanda Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Vanda Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top